Prevention
Prevention
Paying for Health, Not Illness
Our models reveal the impacts of disease and the value of interventions that reduce disease and improve health and longevity.
Our Impact
Featured White Paper
Benefits of Medicare Coverage for Weight Loss Drugs
The cumulative social benefits from Medicare coverage for new obesity treatments over the next 10 years would reach almost $1 trillion, or roughly $100 billion per year.
Experts: Alison Sexton Ward, Bryan Tysinger, PhuongGiang Nguyen, Dana Goldman, Darius Lakdawalla
Top Prevention Stories View All
Evidence Base
A Diabetes Paradox: Better Health, But Still Out of Work
Featured Experts: Jack M. Chapel
In The News View All
Reuters
Kanter discusses the importance of vetting financial conflicts among CDC’s vaccine advisors
Featured Experts: Genevieve P. Kanter
STAT
Expanded coverage of GLP-1s is “probably the single most effective policy” for improving public health, Goldman says
Featured Experts: Dana Goldman
Medscape
Medicare coverage of obesity drugs could presure other insurers to follow suit, Ward says
Featured Experts: Alison Sexton Ward
USC Today
Obesity and diabetes drugs can catalyze profound changes in your body — and in public health, too
Featured Experts: Darius Lakdawalla, Anne Peters, Christopher Scannell
Oprah Daily
Qato discusses disparities in GLP-1 coverage
Featured Experts: Dima M. Qato
Related Subtopics
Chronic diseases are among the most preventable and costliest conditions, consuming the overwhelming majority of Medicare resources. We assemble leading minds from across disciplines to address this challenge, striving to simplify labyrinthine systems of care and promote healthier outcomes.
Team View All Prevention Experts
